Kézdy FJ - Search Results

1

Ionization and surface properties of verapamil and several verapamil analogues.

Retzinger GS, Cohen L, Lau SH, Kézdy FJ. Retzinger GS, et al. Among authors: kezdy fj. J Pharm Sci. 1986 Oct;75(10):976-82. doi: 10.1002/jps.2600751014. J Pharm Sci. 1986. PMID: 3795029

2

The molecular features of verapamil that promote myocardial enzyme leakage.

Cohen L, Morgan J, Kezdy F. Cohen L, et al. Res Commun Chem Pathol Pharmacol. 1986 Mar;51(3):379-92. Res Commun Chem Pathol Pharmacol. 1986. PMID: 3704314

3

Evidence that uncharged verapamil inhibits myocardial contractility.

Cohen L, Vereault D, Wasserstrom JA, Retzinger GS, Kezdy FJ. Cohen L, et al. Among authors: kezdy fj. J Pharmacol Exp Ther. 1987 Aug;242(2):721-5. J Pharmacol Exp Ther. 1987. PMID: 3612559

4

The amphiphilic properties of novenamines determine their activity as inhibitors of HIV-1 RNase H.

Althaus IW, Franks KM, Langley KB, Kézdy FJ, Peterson T, Buxser SE, Decker DE, Dolak LA, Ulrich RG, Reusser F. Althaus IW, et al. Among authors: kezdy fj. Experientia. 1996 Apr 15;52(4):329-35. doi: 10.1007/BF01919535. Experientia. 1996. PMID: 8620935

5

Evidence for transbilayer, tail-to-tail cholesterol dimers in dipalmitoylglycerophosphocholine liposomes.

Harris JS, Epps DE, Davio SR, Kézdy FJ. Harris JS, et al. Among authors: kezdy fj. Biochemistry. 1995 Mar 21;34(11):3851-7. doi: 10.1021/bi00011a043. Biochemistry. 1995. PMID: 7893682

6

Inhibition of the RNA-directed DNA polymerase activity of a recombinant HIV-1 p51 reverse transcriptase by a p15 ribonuclease H domain.

Evans DB, Kézdy FJ, Tarpley G, Sharma SK. Evans DB, et al. Among authors: kezdy fj. Biotechnol Appl Biochem. 1993 Feb;17(1):91-102. Biotechnol Appl Biochem. 1993. PMID: 7679907

7

Novenamines as inhibitors of two independent enzymes during DNA replication in a toluenized Escherichia coli cell system.

Althaus IW, Kézdy FJ, Peterson T, Spilman CH, Reusser F. Althaus IW, et al. Among authors: kezdy fj. Biochem Pharmacol. 1996 May 17;51(10):1373-8. doi: 10.1016/0006-2952(96)00061-5. Biochem Pharmacol. 1996. PMID: 8787554

8

The pretransition of dipalmitoyllecithin bilayers as probed by the fluorescent pyrrolopyrimidine, U-104067.

Epps DE, Wilson CL, Vosters AF, Kézdy FJ. Epps DE, et al. Among authors: kezdy fj. Chem Phys Lipids. 1997 Apr 25;86(2):121-33. doi: 10.1016/s0009-3084(97)02661-3. Chem Phys Lipids. 1997. PMID: 9179994

9

The benzylthio-pyrimidine U-31,355, a potent inhibitor of HIV-1 reverse transcriptase.

Althaus IW, Chou KC, Lemay RJ, Franks KM, Deibel MR, Kezdy FJ, Resnick L, Busso ME, So AG, Downey KM, Romero DL, Thomas RC, Aristoff PA, Tarpley WG, Reusser F. Althaus IW, et al. Among authors: kezdy fj. Biochem Pharmacol. 1996 Mar 22;51(6):743-50. doi: 10.1016/0006-2952(95)02390-9. Biochem Pharmacol. 1996. PMID: 8602869

10

Kinetics and inhibition of lipid exchange catalyzed by plasma cholesteryl ester transfer protein (lipid transfer protein).

Epps DE, Greenlee KA, Harris JS, Thomas EW, Castle CK, Fisher JF, Hozak RR, Marschke CK, Melchior GW, Kézdy FJ. Epps DE, et al. Among authors: kezdy fj. Biochemistry. 1995 Oct 3;34(39):12560-9. doi: 10.1021/bi00039a010. Biochemistry. 1995. PMID: 7548004

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results